Cargando…
Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
Developments in the understanding of the immunopathogenesis of psoriasis have identified interleukin (IL)-17 as the key proinflammatory cytokine in the pathogenesis of plaque psoriasis, with the consequent development of drugs that target this cytokine or associated receptors. Ixekizumab is a subcut...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358983/ https://www.ncbi.nlm.nih.gov/pubmed/28352182 http://dx.doi.org/10.2147/TCRM.S111107 |